Screening of CFTR mutations in an isolated population: Identification of carriers and patients

European Journal of Human Genetics

Volumn 6, Issue 2, 1998, Pages 181-184

  Chiba Falek, Ornit ^a   Nissim Rafinia, Malka ^a   Argaman, Zvi ^b   Genem, Adnan ^c   Moran, Ilana ^c   Kerem, Eitan ^b   Kerem, Batsheva ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

^c Kupat Cholim Clinic   (Israel)

Author keywords

Carrier frequency; CFTR mutations; Disease frequency; Genetic diagnosis; Genetic disease screening; Isolated population

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARAB; ARTICLE; CYSTIC FIBROSIS; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMAN; HUMAN CELL; INCIDENCE; NORMAL HUMAN; POPULATION GENETICS; PRIORITY JOURNAL;

EID: 0031958696     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5200174     Document Type: Article

References (14)

1. Kerem B, Rommens JM, Buchanan JA et al: Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245: 1073-1080.
2. Kerem E, Kalman YM, Yahav Y et al: Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel. Hum Genet 1995; 96: 193-197.
3. Zielenski J, Bozon D, Kerem B, Markiewicz D, Durie P, Rommens JM, Tsui L-C: Identification of mutations in exon 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 1991; 10: 229-235.
4. Chillion M, Casals T, Mercier B, Bassas L, Lissens W, Silber S, Romey M-C: Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995; 332: 1475-1480.
5. Jarvi K, Zielenski J, Wilschanski M et al: Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia. Lancet 1995; 345: 1578.
6. Rave-Hare N, Kerem E, Nissan-Rafinia M et al: The molecular basis of partial penetrance of splicing mutations in cystic fibrosis. Am J Hum Genet 1997; 60: 87-94.
7. Kerem E, Rave-Harel N, Augarten A et al: A CFTR splice variant with partial penetrance associated with variable cystic fibrosis presentation. Am J Respir Crit Care Med 1997; 155: 1914-1920.
8. Zielenski J, Rozmahel R, Bozon D et al: Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 1991; 10: 214-228.
9. Rommens JM, Kerem B, Greer W, Chang P, Tsui L-C, Ray P: Rapid nonradioactive detection of the major cystic fibrosis mutation. Am J Hum Genet 1990; 46: 395-396.
10. Kerem E, Nissim-Rafinia M, Argaman Z et al: A missense cystic fibrosis transmembrane conductance regulator mutation with variable phenotype. Pediatric 1997; 100: 1-6.
11. Welsh MJ, Tsui L-C, Boat TF, Beaudet AL: Cystic fibrosis.. In Scriver CL, Beaudet AL, Sly WS, Valle D (eds): The Metabolic Basis of Inherited Disease, 7th edn. MacGraw-Hill, New York, 1995; pp 3799-3876.
12. Bittles AH, Neel JV: The costs of human inbreeding and their implications for variations at the DNA level. Nat Gen 1994; 8: 117-121.
13. Jaber L, Bailey-Wilson JE, Haj-Yehia M, Hernandez J, Shohat M: Consanguineous matings in an Israeli-Arab community. Arch Pediatr Adolesc Med 1994; 148: 412-415.
14. Abeliovich D, Quint A, Weinberg N, Verechozon G, Lerer I, Ekstein J, Rubinstein E: CF heterozygote screening in the orthodox community of the Ashkenazi Jews: the 'Dor Yesharim' approach and heterozygote frequency. Eur J Hum Genet 1996; 4: 338-341.